Literature DB >> 24086643

Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction.

Sanda Predescu1, Ivana Knezevic, Cristina Bardita, Radu Florin Neamu, Viktor Brovcovych, Dan Predescu.   

Abstract

The spatial and functional relationship between platelet activating factor-receptor (PAF-R) and nitric oxide synthase (eNOS) in the lateral plane of the endothelial plasma membrane is poorly characterized. In this study, we used intact mouse pulmonary endothelial cells (ECs) as well as endothelial plasma membrane patches and subcellular fractions to define a new microdomain of plasmalemma proper where the two proteins colocalize and to demonstrate how PAF-mediated nitric oxide (NO) production fine-tunes ECs function as gatekeepers of vascular permeability. Using fluorescence microscopy and immunogold labeling electron microscopy (EM) on membrane patches we demonstrate that PAF-R is organized as clusters and colocalizes with a subcellular pool of eNOS, outside recognizable vesicular profiles. Moreover, PAF-induced acid sphingomyelinase activation generates a ceramide-based microdomain on the external leaflet of plasma membrane, inside of which a signalosome containing eNOS shapes PAF-stimulated NO production. Real-time measurements of NO after PAF-R ligation indicated a rapid (5 to 15 min) increase in NO production followed by a > 45 min period of reduction to basal levels. Moreover, at the level of this new microdomain, PAF induces a dynamic phosphorylation/dephosphorylation of Ser, Thr and Tyr residues of eNOS that correlates with NO production. Altogether, our findings establish the existence of a functional partnership PAF-R/eNOS on EC plasma membrane, at the level of PAF-induced ceramide plasma membrane microdomains, outside recognized vesicular profiles.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24086643      PMCID: PMC3785431          DOI: 10.1371/journal.pone.0075846

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  69 in total

1.  VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor.

Authors:  M G Sirois; E R Edelman
Journal:  Am J Physiol       Date:  1997-06

Review 2.  PAF-acether (platelet-activating factor).

Authors:  J Benveniste
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1989

3.  Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers.

Authors:  Jesús Sot; Luis A Bagatolli; Félix M Goñi; Alicia Alonso
Journal:  Biophys J       Date:  2005-11-11       Impact factor: 4.033

4.  Transcytosis of alpha1-acidic glycoprotein in the continuous microvascular endothelium.

Authors:  D Predescu; S Predescu; T McQuistan; G E Palade
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization.

Authors:  J Liu; G García-Cardeña; W C Sessa
Journal:  Biochemistry       Date:  1996-10-15       Impact factor: 3.162

6.  Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells.

Authors:  T A Brock; M A Gimbrone
Journal:  Am J Physiol       Date:  1986-06

7.  Direct electrochemical measurement of nitric oxide in vascular endothelium.

Authors:  V Brovkovych; E Stolarczyk; J Oman; P Tomboulian; T Malinski
Journal:  J Pharm Biomed Anal       Date:  1999-02       Impact factor: 3.935

8.  Colocalization of eNOS and the catalytic subunit of PKA in endothelial cell junctions: a clue for regulated NO production.

Authors:  Harry F G Heijnen; Sandra Waaijenborg; James D Crapo; Russell P Bowler; Jan-Willem N Akkerman; Jan W Slot
Journal:  J Histochem Cytochem       Date:  2004-10       Impact factor: 2.479

9.  Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine.

Authors:  D M Humphrey; L M McManus; D J Hanahan; R N Pinckard
Journal:  Lab Invest       Date:  1984-01       Impact factor: 5.662

Review 10.  Life history of eNOS: partners and pathways.

Authors:  David M Dudzinski; Thomas Michel
Journal:  Cardiovasc Res       Date:  2007-04-03       Impact factor: 10.787

View more
  9 in total

1.  Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells.

Authors:  Eugen Brailoiu; Christine L Barlow; Servio H Ramirez; Mary E Abood; G Cristina Brailoiu
Journal:  Neuroscience       Date:  2018-03-06       Impact factor: 3.590

Review 2.  Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.

Authors:  Jeffrey W Meeusen; Leslie J Donato; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 3.  Sphingolipid metabolites in inflammatory disease.

Authors:  Michael Maceyka; Sarah Spiegel
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

4.  Immunization associated with erectile dysfunction based on cross-sectional and genetic analyses.

Authors:  Yang Chen; Xianxiang Xin; Haiying Zhang; Jianfeng Xu; Yong Gao; Aihua Tan; Xiaobo Yang; Xue Qin; Yanling Hu; Zengnan Mo
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

5.  Mouse Lung Fibroblast Resistance to Fas-Mediated Apoptosis Is Dependent on the Baculoviral Inhibitor of Apoptosis Protein 4 and the Cellular FLICE-Inhibitory Protein.

Authors:  Sanda A Predescu; Jian Zhang; Cristina Bardita; Monal Patel; Varun Godbole; Dan N Predescu
Journal:  Front Physiol       Date:  2017-03-14       Impact factor: 4.566

6.  Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: An observational study.

Authors:  Joy N Jones Buie; Samar M Hammad; Paul J Nietert; Gayenell Magwood; Robert J Adams; Leonardo Bonilha; Catrina Sims-Robinson
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

7.  Dietary Fatty Acid Saturation Modulates Sphingosine-1-Phosphate-Mediated Vascular Function.

Authors:  Daniel W Nuno; Kathryn G Lamping
Journal:  J Diabetes Res       Date:  2019-08-25       Impact factor: 4.011

Review 8.  Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development.

Authors:  Kabir Ahluwalia; Brandon Ebright; Kingsley Chow; Priyal Dave; Andrew Mead; Roy Poblete; Stan G Louie; Isaac Asante
Journal:  Metabolites       Date:  2022-04-07

Review 9.  Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons.

Authors:  Nadine Beckmann; Deepa Sharma; Erich Gulbins; Katrin Anne Becker; Bärbel Edelmann
Journal:  Front Physiol       Date:  2014-09-02       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.